| Identification | Back Directory | [Name]
Propanamide, N-[(1S,2R)-2-(3,5-difluorophenyl)-1-methyl-2-[[1-(1,2,4-triazolo[4,3-a]pyridin-6-yl)-1H-indazol-5-yl]oxy]ethyl]-2,2-difluoro- | [CAS]
2664932-65-2 | [Synonyms]
Glucocorticoid receptor-IN-2
Propanamide, N-[(1S,2R)-2-(3,5-difluorophenyl)-1-methyl-2-[[1-(1,2,4-triazolo[4,3-a]pyridin-6-yl)-1H-indazol-5-yl]oxy]ethyl]-2,2-difluoro- | [Molecular Formula]
C25H20F4N6O2 | [MOL File]
2664932-65-2.mol | [Molecular Weight]
512.46 |
| Hazard Information | Back Directory | [Uses]
Glucocorticoid receptor-IN-2 (Compound WX019) is a selective glucocorticoid receptor (GR) modulator with anti-inflammatory effect. Glucocorticoid receptor-IN-2 exhibits very good transcriptional repressive activity with an IC50 of 0.171 nM against hMMP1, and comparable transcriptional activation activity with an EC50 of 0.94 nM against MMTV[1]. | [References]
[1] Sheng Su, et al. Benzopyrazole compound. WO2021136429. |
|
|